Last reviewed · How we verify

NCT03720015

Concurrent Training and Nutritional Management in Cancer

Completed NA Last updated 29 November 2018
What this trial tests

NA trial testing Physical exercise in Body Weight Changes in 1 participant. Completed in 17 September 2017.

Timeline
20 July 2017
Primary endpoint
24 July 2017
17 September 2017

Quick facts

Lead sponsorUniversidad Francisco de Vitoria
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment1
Start date20 July 2017
Primary completion24 July 2017
Estimated completion17 September 2017
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Francisco de Vitoria — full company profile →

Who can join

Adults 32 to 34, male only, with Body Weight Changes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A case control study with before-after design. A concurrent training and a nutritional management intervention was offered by a patient with head and neck cancer, in order to compare outcomes related to strength and endurance performance and to body composition

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy.
    Singh A, Alexander SG, Martin S. · · 2023 · cited 35× · PMID 37261348 · DOI 10.3389/fimmu.2023.1114499

Verify or expand the search:

Other trials of Physical exercise

Trials testing the same drug.

Other recruiting trials for Body Weight Changes

Currently open trials in the same condition.

Other Universidad Francisco de Vitoria trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03720015.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing